The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study

Objective: In this study, we aimed to investigate the efficacy and safety of azacitidine (AZA) in elderly patients with acute myeloid leukemia (AML), including patients with >30% bone marrow (BM) blasts. Materials and Methods: In this retrospective multicenter study, 130 patients of ≥60 years...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Anıl Tombak, Mehmet Ali Uçar, Aydan Akdeniz, Eyüp Naci Tiftik, Deniz Gören Şahin, Olga Meltem Akay, Murat Yıldırım, Oral Nevruz, Cem Kis, Emel Gürkan, Şerife Medeni Solmaz, Mehmet Ali Özcan, Rahşan Yıldırım, İlhami Berber, Mehmet Ali Erkurt, Tülin Fıratlı Tuğlular, Pınar Tarkun, İrfan Yavaşoğlu, Mehmet Hilmi Doğu, İsmail Sarı, Mustafa Merter, Muhit Özcan, Esra Yıldızhan, Leylagül Kaynar, Özgür Mehtap, Ayşe Uysal, Fahri Şahin, Ozan Salim, Mehmet Ali Sungur
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Turkish Society of Hematology 2016-11-01
Colecção:	Turkish Journal of Hematology
Assuntos:	azacitidine acute myeloid leukemia elderly bone marrow blasts prognostic factors overall survival
Acesso em linha:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-55632
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!